Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2015, Article ID 189341, 10 pages
http://dx.doi.org/10.1155/2015/189341
Research Article

Procoagulatory State in Inflammatory Bowel Diseases Is Promoted by Impaired Intestinal Barrier Function

1Gastroenterology and Gastrointestinal Endoscopy Unit, IRCCS Policlinico San Donato, 20097 San Donato Milanese, Italy
2Department of Biomedical Sciences for Health, University of Milan, 20131 Milan, Italy
3Angelo Bianchi Bonomi Hemophilia and Thrombosis Centre, IRCCS Ca’ Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy
4Department of Medical and Surgical Pathophysiology and Transplantations, University of Milan, 20122 Milan, Italy
5Operative Unit of Laboratory Medicine, IRCCS Policlinico San Donato, 20097 San Donato Milanese, Italy

Received 29 October 2014; Revised 27 January 2015; Accepted 1 February 2015

Academic Editor: Gerassimos Mantzaris

Copyright © 2015 Luca Pastorelli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Rosamond, K. Flegal, K. Furie et al., “Heart disease and stroke statistics—2008 update: a report from the American heart association statistics committee and stroke statistics subcommittee,” Circulation, vol. 117, no. 4, pp. e25–e46, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. C. T. Esmon, “Inflammation and thrombosis,” Journal of Thrombosis and Haemostasis, vol. 1, no. 7, pp. 1343–1348, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Petaja, “Inflammation and coagulation. An overview,” Thrombosis Research, vol. 127, supplement 2, pp. S34–S37, 2011. View at Publisher · View at Google Scholar
  4. J. Frostegård, “Immunity, atherosclerosis and cardiovascular disease,” BMC Medicine, vol. 11, no. 1, article 117, 2013. View at Publisher · View at Google Scholar
  5. K. J. Moore, F. J. Sheedy, and E. A. Fisher, “Macrophages in atherosclerosis: a dynamic balance,” Nature Reviews Immunology, vol. 13, no. 10, pp. 709–721, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Zoller, X. Li, J. Sundquist, and K. Sundquist, “Autoimmune diseases and venous thromboembolism: a review of the literature,” American Journal of Cardiovascular Disease, vol. 2, no. 3, pp. 171–183, 2012. View at Google Scholar
  7. W. Miehsler, W. Reinisch, E. Valic et al., “Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?” Gut, vol. 53, no. 4, pp. 542–548, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Kaser, S. Zeissig, and R. S. Blumberg, “Inflammatory bowel disease,” Annual Review of Immunology, vol. 28, pp. 573–621, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Pastorelli, C. D. Salvo, J. R. Mercado, M. Vecchi, and T. T. Pizarro, “Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: iessons learned from animal models and human genetics,” Frontiers in Immunology, vol. 4, article 280, Article ID Article 280, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Zaeem Cader and A. Kaser, “Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation,” Gut, vol. 62, no. 11, pp. 1653–1664, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Saibeni, L. Spina, and M. Vecchi, “Exploring the relationships between inflammatory response and coagulation cascade in inflammatory bowel disease,” European Review for Medical and Pharmacological Sciences, vol. 8, no. 5, pp. 205–208, 2004. View at Google Scholar · View at Scopus
  12. S. Saibeni, M. Cattaneo, M. Vecchi et al., “Low vitamin B6 plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants,” The American Journal of Gastroenterology, vol. 98, no. 1, pp. 112–117, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Cattaneo, M. Vecchi, M. L. Zighetti et al., “High prevalence of hyperhomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications?” Thrombosis and Haemostasis, vol. 80, no. 4, pp. 542–545, 1998. View at Google Scholar · View at Scopus
  14. T. H. Mogensen, “Pathogen recognition and inflammatory signaling in innate immune defenses,” Clinical Microbiology Reviews, vol. 22, no. 2, pp. 240–273, 2009. View at Publisher · View at Google Scholar
  15. E. LeBouder, J. E. Rey-Nores, N. K. Rushmere et al., “Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk,” Journal of Immunology, vol. 171, no. 12, pp. 6680–6689, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. K. I. Iwami, T. Matsuguchi, A. Masuda, T. Kikuchi, T. Musikacharoen, and Y. Yoshikai, “Cutting edge: naturally occurring soluble form of mouse toll-like receptor 4 inhibits lipopolysaccharide signaling,” Journal of Immunology, vol. 165, no. 12, pp. 6682–6686, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. I. Muñoz, M. P. Sepulcre, J. Meseguer, and V. Mulero, “Molecular cloning, phylogenetic analysis and functional characterization of soluble Toll-like receptor 5 in gilthead seabream, Sparus aurata,” Fish & Shellfish Immunology, vol. 35, no. 1, pp. 36–45, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. S. L. Zunt, L. V. Burton, L. I. Goldblatt, E. E. Dobbins, and M. Srinivasan, “Soluble forms of Toll-like receptor 4 are present in human saliva and modulate tumour necrosis factor-α secretion by macrophage-like cells,” Clinical and Experimental Immunology, vol. 156, no. 2, pp. 285–293, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. A.-C. Raby, E. le Bouder, C. Colmont et al., “Soluble TLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggering,” Journal of Immunology, vol. 183, no. 1, pp. 506–517, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. R.-S. Chang, Y.-C. Wang, and S.-T. Kao, “Soluble toll-like receptor 4 reversed attenuating effect of Chinese herbal Xiao-Qing-Long-Tang on allergen induced nerve growth factor and thymic stromal lymphopoietin,” Experimental and Therapeutic Medicine, vol. 6, no. 5, pp. 1199–1207, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Kondelkova, J. Krejsek, L. Borska et al., “Membrane and soluble Toll-like receptor 2 in patients with psoriasis treated by Goeckerman therapy,” International Journal of Dermatology, vol. 53, no. 11, pp. e512–e517, 2014. View at Publisher · View at Google Scholar
  22. H.-B. Yang, K.-Q. Xie, J.-M. Deng, and S.-M. Qin, “Expression of soluble toll-like receptors in pleural effusions,” Chinese Medical Journal, vol. 123, no. 16, pp. 2225–2230, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Galliera, L. Drago, C. Vassena et al., “Toll-like receptor 2 in serum: a potential diagnostic marker of prosthetic joint infection?” Journal of Clinical Microbiology, vol. 52, no. 2, pp. 620–623, 2013. View at Publisher · View at Google Scholar
  24. A. Zhao, C. Blackburn, J. Chin, and M. Srinivasan, “Soluble toll like receptor 2 (TLR-2) is increased in saliva of children with dental caries,” BMC Oral Health, vol. 14, no. 1, article 108, 2014. View at Publisher · View at Google Scholar
  25. M. E. Houssen, R. H. El-Mahdy, and D. A. Shahin, “Serum soluble toll-like receptor 2: a novel biomarker for systemic lupus erythematosus disease activity and lupus-related cardiovascular dysfunction,” International Journal of Rheumatic Diseases, 2014. View at Publisher · View at Google Scholar
  26. E. Candia, D. Díaz-Jiménez, P. Langjahr et al., “Increased production of soluble TLR2 by lamina propria mononuclear cells from ulcerative colitis patients,” Immunobiology, vol. 217, no. 6, pp. 634–642, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Cognasse, H. Hamzeh, P. Chavarin, S. Acquart, C. Genin, and O. Garraud, “Evidence of Toll-like receptor molecules on human platelets,” Immunology and Cell Biology, vol. 83, no. 2, pp. 196–198, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. F. X. Zhang, C. J. Kirschning, R. Mancinelli et al., “Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes,” The Journal of Biological Chemistry, vol. 274, no. 12, pp. 7611–7614, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Faure, O. Equils, P. A. Sieling et al., “Bacterial lipopolysaccharide activates NF-κB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells,” The Journal of Biological Chemistry, vol. 275, no. 15, pp. 11058–11063, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. M. D. Boisclair, H. Ireland, and D. A. Lane, “Assessment of hypercoagulable states by measurement of activation fragments and peptides,” Blood Reviews, vol. 4, no. 1, pp. 25–40, 1990. View at Publisher · View at Google Scholar · View at Scopus
  31. E. F. Stange, S. P. L. Travis, S. Vermeire et al., “European evidence-based Consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis,” Journal of Crohn's & Colitis, vol. 2, no. 1, pp. 1–23, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Dignass, G. van Assche, J. O. Lindsay et al., “The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: current management,” Journal of Crohn's & Colitis, vol. 4, no. 1, pp. 28–62, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. R. F. Harvey and J. M. Bradshaw, “A simple index of Crohn's-disease activity,” The Lancet, vol. 1, no. 8167, p. 514, 1980. View at Google Scholar · View at Scopus
  34. K. W. Schroeder, W. J. Tremaine, and D. M. Ilstrup, “Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis: a randomized study,” The New England Journal of Medicine, vol. 317, no. 26, pp. 1625–1629, 1987. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Satsangi, M. S. Silverberg, S. Vermeire, and J.-F. Colombel, “The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications,” Gut, vol. 55, no. 6, pp. 749–753, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. R. G. Shorter, K. A. Huizenga, and R. J. Spencer, “A working hypothesis for the etiology and pathogenesis of nonspecific inflammatory bowel disease,” The American Journal of Digestive Diseases, vol. 17, no. 11, pp. 1024–1032, 1972. View at Publisher · View at Google Scholar · View at Scopus
  37. A. I. Thompson and C. W. Lees, “Genetics of ulcerative colitis,” Inflammatory Bowel Diseases, vol. 17, no. 3, pp. 831–848, 2011. View at Publisher · View at Google Scholar
  38. C. W. Lees, J. C. Barrett, M. Parkes, and J. Satsangi, “New IBD genetics: common pathways with other diseases,” Gut, vol. 60, no. 12, pp. 1739–1753, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. G. C. Nguyen and J. Sam, “Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients,” The American Journal of Gastroenterology, vol. 103, no. 9, pp. 2272–2280, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Yuhara, C. Steinmaus, D. Corley et al., “Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease,” Alimentary Pharmacology and Therapeutics, vol. 37, no. 10, pp. 953–962, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. W. R. Swindell, P. E. Stuart, M. K. Sarkar et al., “Cellular dissection of psoriasis for transcriptome analyses and the post-GWAS era,” Acta Veterinaria Scandinavica, vol. 7, article 27, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. D. Salem, R. Subang, P. Laplante, J. Levine, and J. Rauch, “The dual role of innate immunity in antiphospholipid syndrome and systemic lupus erythematosus,” Lupus, vol. 23, no. 12, pp. 1327–1331, 2014. View at Publisher · View at Google Scholar
  43. P. Blair, S. Rex, O. Vitseva et al., “Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase,” Circulation Research, vol. 104, no. 3, pp. 346–354, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Kälvegren, C. Skoglund, C. Helldahl, M. Lerm, M. Grenegård, and T. Bengtsson, “Toll-like receptor 2 stimulation of platelets is mediated by purinergic P2X1-dependent Ca2+ mobilisation, cyclooxygenase and purinergic P2Y1 and P2Y12 receptor activation,” Thrombosis and Haemostasis, vol. 103, no. 2, pp. 398–407, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Rex, L. M. Beaulieu, D. H. Perlman et al., “Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein-protein interactions, and α-granule release,” Thrombosis and Haemostasis, vol. 102, no. 1, pp. 97–110, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. G. Zhang, J. Han, E. J. Welch et al., “Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway,” The Journal of Immunology, vol. 182, no. 12, pp. 7997–8004, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. G. T. Brown and T. M. McIntyre, “Lipopolysaccharide signaling without a nucleus: kinase cascades stimulate platelet shedding of proinflammatory IL-1β-rich microparticles,” The Journal of Immunology, vol. 186, no. 9, pp. 5489–5496, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. L. Chávez-Sánchez, J. E. Espinosa-Luna, K. Chávez-Rueda, M. V. Legorreta-Haquet, E. Montoya-Díaz, and F. Blanco-Favela, “Innate immune system cells in atherosclerosis,” Archives of Medical Research, vol. 45, no. 1, pp. 1–14, 2014. View at Publisher · View at Google Scholar · View at Scopus